Follow
Colm Andrews
Colm Andrews
Unknown affiliation
Verified email at phc.ox.ac.uk
Title
Cited by
Cited by
Year
Description of the updated nutrition calculation of the Oxford WebQ questionnaire and comparison with the previous version among 207,144 participants in UK Biobank
A Perez-Cornago, Z Pollard, H Young, M van Uden, C Andrews, ...
European journal of nutrition 60 (7), 4019-4030, 2021
822021
Long-term efficacy and tolerability of TNFα inhibitors in the treatment of non-infectious ocular inflammation: an 8-year prospective surveillance study
SM Sharma, E Damato, AE Hinchcliffe, CD Andrews, K Myint, R Lee, ...
British Journal of Ophthalmology 105 (9), 1256-1262, 2021
442021
OpenSAFELY: Representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of England
C Andrews, A Schultze, H Curtis, W Hulme, J Tazare, S Evans, A Mehrkar, ...
Wellcome Open Research 7, 2022
392022
Impaired dark adaptation associated with a diseased Bruch membrane in pseudoxanthoma elasticum
K Hess, M Gliem, J Birtel, P Müller, D Hendig, C Andrews, IJ Murray, ...
Retina 40 (10), 1988-1995, 2020
272020
Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia
EL Watts, A Perez‐Cornago, GK Fensom, K Smith‐Byrne, U Noor, ...
International journal of cancer 151 (7), 1033-1046, 2022
252022
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY
OpenSAFELY Collaborative, A Green, H Curtis, W Hulme, E Williamson, ...
BMC medicine 20 (1), 243, 2022
252022
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform
L Nab, EPK Parker, CD Andrews, WJ Hulme, L Fisher, J Morley, ...
The Lancet public health 8 (5), e364-e377, 2023
242023
Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP
WJ Hulme, EMF Horne, EPK Parker, RH Keogh, EJ Williamson, V Walker, ...
bmj 380, 2023
222023
Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian …
EL Watts, A Perez-Cornago, GK Fensom, K Smith-Byrne, U Noor, ...
International journal of epidemiology 52 (1), 71-86, 2023
222023
Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective …
ACA Green, HJ Curtis, R Higgins, L Nab, V Mahalingasivam, RM Smith, ...
BMJ medicine 2 (1), 2023
162023
Sleep–wake disturbance related to ocular disease: a systematic review of phase-shifting pharmaceutical therapies
CD Andrews, RG Foster, I Alexander, S Vasudevan, SM Downes, ...
Translational Vision Science & Technology 8 (3), 49-49, 2019
142019
Low-contrast visual acuity versus low-luminance visual acuity in choroideremia
LJ Wood, JK Jolly, CD Andrews, IR Wilson, D Hickey, ...
Clinical and Experimental Optometry 104 (1), 90-94, 2021
122021
Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank
A Perez-Cornago, GK Fensom, C Andrews, EL Watts, NE Allen, ...
British Journal of Cancer 123 (12), 1808-1817, 2020
122020
Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY
MD Russell, JB Galloway, CD Andrews, B MacKenna, B Goldacre, ...
The Lancet Rheumatology 4 (12), e853-e863, 2022
102022
Changes in COVID-19-related mortality across key demographic and clinical subgroups: an observational cohort study using the OpenSAFELY platform on 18 million adults in England
OpenSAFELY Collaborative, L Nab, EPK Parker, CD Andrews, WJ Hulme, ...
medRxiv, 2022.07. 30.22278161, 2022
92022
OpenSAFELY: Representativeness of Electronic Health Record platform OpenSAFELY-TPP data compared to the population of England. medRxiv. 2022; 2022.06. 23.22276802
CD Andrews, A Schultze, HJ Curtis, W Hulme, J Tazare, S Evans
Publisher Full Text, 0
6
Systemic corticosteroid use in UK Uveitis practice: results from the ocular inflammation steroid toxicity risk (OSTRICH) study
L Leandro, N Beare, K Bhan, PI Murray, C Andrews, E Damato, ...
Eye 35 (12), 3342-3349, 2021
52021
Effectiveness of BNT162b2 booster doses in England: an observational study in OpenSAFELY-TPP
WJ Hulme, EJ Williamson, E Horne, A Green, L Nab, R Keogh, ...
medRxiv, 2022.06. 06.22276026, 2022
42022
The impact of COVID-19 on prescribing of pancreatic enzyme replacement therapy for people with unresectable pancreatic cancer in England. A cohort study using OpenSafely-TPP
A Lemanska, C Andrews, L Fisher, B Butler-Cole, A Mehrkar, KJ Roberts, ...
medRxiv, 2022.07. 08.22277317, 2022
32022
Clinical and health inequality risk factors for non-COVID-related sepsis during the global COVID-19 pandemic: a national case-control and cohort study
X Zhong, D Ashiru-Oredope, A Pate, GP Martin, A Sharma, P Dark, ...
EClinicalMedicine 66, 2023
22023
The system can't perform the operation now. Try again later.
Articles 1–20